BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 30179224)

  • 21. Sumoylation of MDC1 is important for proper DNA damage response.
    Luo K; Zhang H; Wang L; Yuan J; Lou Z
    EMBO J; 2012 Jun; 31(13):3008-19. PubMed ID: 22635276
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A feedforward circuit shaped by ECT2 and USP7 contributes to breast carcinogenesis.
    Zhang Q; Cao C; Gong W; Bao K; Wang Q; Wang Y; Bi L; Ma S; Zhao J; Liu L; Tian S; Zhang K; Yang J; Yao Z; Song N; Shi L
    Theranostics; 2020; 10(23):10769-10790. PubMed ID: 32929379
    [No Abstract]   [Full Text] [Related]  

  • 23. MDC1 is required for the intra-S-phase DNA damage checkpoint.
    Goldberg M; Stucki M; Falck J; D'Amours D; Rahman D; Pappin D; Bartek J; Jackson SP
    Nature; 2003 Feb; 421(6926):952-6. PubMed ID: 12607003
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NFBD1/MDC1 regulates ionizing radiation-induced focus formation by DNA checkpoint signaling and repair factors.
    Xu X; Stern DF
    FASEB J; 2003 Oct; 17(13):1842-8. PubMed ID: 14519663
    [TBL] [Abstract][Full Text] [Related]  

  • 25. LRH1 enhances cell resistance to chemotherapy by transcriptionally activating MDC1 expression and attenuating DNA damage in human breast cancer.
    Wang S; Zou Z; Luo X; Mi Y; Chang H; Xing D
    Oncogene; 2018 Jun; 37(24):3243-3259. PubMed ID: 29545602
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mdc1 modulates the interaction between TopBP1 and the MRN complex during DNA damage checkpoint responses.
    Choi SH; Yoo HY
    Biochem Biophys Res Commun; 2016 Oct; 479(1):5-11. PubMed ID: 27590578
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MDC1 interacts with Rad51 and facilitates homologous recombination.
    Zhang J; Ma Z; Treszezamsky A; Powell SN
    Nat Struct Mol Biol; 2005 Oct; 12(10):902-9. PubMed ID: 16186822
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNA-22 Suppresses DNA Repair and Promotes Genomic Instability through Targeting of MDC1.
    Lee JH; Park SJ; Jeong SY; Kim MJ; Jun S; Lee HS; Chang IY; Lim SC; Yoon SP; Yong J; You HJ
    Cancer Res; 2015 Apr; 75(7):1298-310. PubMed ID: 25627978
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Loss of MDC1 in Endometrial Carcinoma Is Associated With Loss of MRN Complex and MMR Deficiency.
    Merentitis D; Nguyen BD; Samartzis EP; Noske A; Brandt S; Dedes KJ
    Anticancer Res; 2019 Dec; 39(12):6547-6553. PubMed ID: 31810920
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional defects of cancer-associated MDC1 mutations in DNA damage repair.
    Xie R; Yan Z; Jing J; Wang Y; Zhang J; Li Y; Liu X; Yu X; Wu C
    DNA Repair (Amst); 2022 Jun; 114():103330. PubMed ID: 35378404
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ID3 regulates the MDC1-mediated DNA damage response in order to maintain genome stability.
    Lee JH; Park SJ; Hariharasudhan G; Kim MJ; Jung SM; Jeong SY; Chang IY; Kim C; Kim E; Yu J; Bae S; You HJ
    Nat Commun; 2017 Oct; 8(1):903. PubMed ID: 29026069
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mediator of DNA damage checkpoint protein 1 (MDC1) expression as a prognostic marker for nodal recurrence in early-stage breast cancer patients treated with breast-conserving surgery and radiation therapy.
    Patel AN; Goyal S; Wu H; Schiff D; Moran MS; Haffty BG
    Breast Cancer Res Treat; 2011 Apr; 126(3):601-7. PubMed ID: 20521098
    [TBL] [Abstract][Full Text] [Related]  

  • 33. STAT-1 facilitates the ATM activated checkpoint pathway following DNA damage.
    Townsend PA; Cragg MS; Davidson SM; McCormick J; Barry S; Lawrence KM; Knight RA; Hubank M; Chen PL; Latchman DS; Stephanou A
    J Cell Sci; 2005 Apr; 118(Pt 8):1629-39. PubMed ID: 15784679
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The in vivo dynamic interplay of MDC1 and 53BP1 at DNA damage-induced nuclear foci.
    Mok MT; Henderson BR
    Int J Biochem Cell Biol; 2012 Sep; 44(9):1398-409. PubMed ID: 22677490
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumors overexpressing RNF168 show altered DNA repair and responses to genotoxic treatments, genomic instability and resistance to proteotoxic stress.
    Chroma K; Mistrik M; Moudry P; Gursky J; Liptay M; Strauss R; Skrott Z; Vrtel R; Bartkova J; Kramara J; Bartek J
    Oncogene; 2017 Apr; 36(17):2405-2422. PubMed ID: 27841863
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Expression of DNA damage checkpoint mediator 1 and p53-binding protein 1 in human esophageal cancer cell lines TE-1, TE-13, and Eca109].
    Liu ZK; Zhu SC; Wang YX
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Sep; 27(9):1314-7. PubMed ID: 17884766
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A role for the deubiquitinating enzyme USP28 in control of the DNA-damage response.
    Zhang D; Zaugg K; Mak TW; Elledge SJ
    Cell; 2006 Aug; 126(3):529-42. PubMed ID: 16901786
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ribosomal protein L6 (RPL6) is recruited to DNA damage sites in a poly(ADP-ribose) polymerase-dependent manner and regulates the DNA damage response.
    Yang C; Zang W; Ji Y; Li T; Yang Y; Zheng X
    J Biol Chem; 2019 Feb; 294(8):2827-2838. PubMed ID: 30598506
    [TBL] [Abstract][Full Text] [Related]  

  • 39. UBE2O and USP7 co-regulate RECQL4 ubiquitinylation and homologous recombination-mediated DNA repair.
    Huang Q; Qin D; Pei D; Vermeulen M; Zhang X
    FASEB J; 2022 Jan; 36(1):e22112. PubMed ID: 34921745
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MDC1 depletion promotes cisplatin induced cell death in cervical cancer cells.
    Singh N; Bhakuni R; Chhabria D; Kirubakaran S
    BMC Res Notes; 2020 Mar; 13(1):146. PubMed ID: 32160908
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.